Pacer Advisors
DYN icon

Pacer Advisors’s Dyne Therapeutics DYN Stock Holding History

Pacer Advisors’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43K Buy
+1,922
New +$35.7K ﹤0.01% 2070
2024
Q3 		– Sell
-827
Closed -$29.2K – 2600
2024
Q2 		$29.2K Sell
827
-773
-48% -$22.5K ﹤0.01% 3350
2024
Q1 		$45.4K Buy
+1,600
New +$36.2K ﹤0.01% 3206

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Pacer Advisors's DYN Position: Q2 2026 in Review

Pacer Advisors opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 1,922 shares worth $43K. The stake represents ﹤0.01% of the portfolio and ranks #2070 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in DYN as recently as Q2 2024.

Pacer Advisors first reported a position in DYN in Q1 2024 and has held it in 3 quarters since. The position peaked at $45.4K in Q1 2024. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Pacer Advisors held 1,922 shares of Dyne Therapeutics worth $43K as of Q2 2026.
  • Dyne Therapeutics was a new Pacer Advisors position in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2070 holding.
  • Pacer Advisors first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Pacer Advisors's Dyne Therapeutics position peaked at $45.4K in Q1 2024.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.